Article Information
PubMed
Published By
History
- Received August 21, 2002
- Revision received October 15, 2002
- Accepted November 18, 2002
- First published February 1, 2003.
- Version of record published February 1, 2003.
Copyright & Usage
Copyright © 2003 Society for Neuroscience
Author Information
- Paul M. Thompson1,
- Kiralee M. Hayashi1,
- Greig de Zubicaray2,
- Andrew L. Janke2,
- Stephen E. Rose2,
- James Semple3,
- David Herman1,
- Michael S. Hong1,
- Stephanie S. Dittmer1,
- David M. Doddrell2, and
- Arthur W. Toga1
- 1Laboratory of Neuro Imaging, Brain Mapping Division, Department of Neurology, University of California Los Angeles School of Medicine, Los Angeles, California 90095,
- 2Centre for Magnetic Resonance, University of Queensland, Brisbane, QLD 4072, Australia, and
- 3GlaxoSmithKline Pharmaceuticals, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, CB2 2GG, Cambridge, United Kingdom
Author contributions
Disclosures
- Received August 21, 2002.
- Revision received October 15, 2002.
- Accepted November 18, 2002.
This work was supported by National Library of Medicine Grant R01 LM05639, by National Center for Research Resources Grants P41 RR13642 and M01 RR00865, by a grant from GlaxoSmithKline Pharmaceuticals UK, and by Human Brain Project Grant P01 MH52176 to the International Consortium for Brain Mapping, which is funded jointly by the National Institute of Mental Health and the National Institute on Drug Abuse.
Correspondence should be addressed to Dr. Paul Thompson, Room 4238, Reed Neurological Research Center, Laboratory of Neuro Imaging, Department of Neurology, University of California Los Angeles School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095-1769. E-mail:thompson{at}loni.ucla.edu.
Online Impact